Advertisement

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia

Christopher J. Ott, Nadja Kopp, Liat Bird, Ronald M. Paranal, Jun Qi, Teresa Bowman, Scott J. Rodig, Andrew L. Kung, James E. Bradner and David M. Weinstock

Article Information

Citation 
vol. 120 no. 14 2843-2852
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted February 23, 2012
  • Accepted August 2, 2012
  • Published online October 4, 2012.


Contributors 
  • Christopher J. Ott, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2Harvard Medical School, Boston, MA;
  • Nadja Kopp, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2Harvard Medical School, Boston, MA;
  • Liat Bird, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2Harvard Medical School, Boston, MA;
  • Ronald M. Paranal, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2Harvard Medical School, Boston, MA;
  • Jun Qi, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2Harvard Medical School, Boston, MA;
  • Teresa Bowman, 2Harvard Medical School, Boston, MA;3Department of Pathology, Brigham and Women's Hospital, Boston, MA; and
  • Scott J. Rodig, 2Harvard Medical School, Boston, MA;3Department of Pathology, Brigham and Women's Hospital, Boston, MA; and
  • Andrew L. Kung, 2Harvard Medical School, Boston, MA;4Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
  • James E. Bradner, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2Harvard Medical School, Boston, MA;
  • David M. Weinstock, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2Harvard Medical School, Boston, MA;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output